Recent TCRX Stock Price | TCRX Stock Predictions | |
$8.65 | +34.10% |
$11.60 |
Recent TCRX Analyst Ratings Breakdown, Making TCRX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 6 | 6 | 6 | 6 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the TCRX stock predictions from the analysts covering TScan Therapeutics Inc, we have collected all of the individual TCRX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 5 different analysts covering TCRX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since TCRX stock predictions may vary widely, another useful metric to consider is the median TCRX stock prediction, which represents the price at which half of the analysts
made TCRX stock predictions that were higher and half made TCRX stock predictions that were lower. This makes for a different take on the TCRX stock predictions out there, as compared to average or mean.
And that median across all the individual TCRX stock predictions was: $10.0 as of 2024-05-03.
The very highest of the TCRX stock predictions for one year price target was $15.0, while the very lowest of the TCRX stock predictions in the analyst group was
$9.0 (with a standard deviation of $2.701). Get the latest Zacks research report on TCRX — FREE
Find out: TCRX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
VLY Stock Predictions
FOSL Stock Predictions
NX Stock Predictions
BGS Stock Predictions
HUN Stock Predictions
SAH Stock Predictions
ITGR Stock Predictions
INTC Stock Predictions
IQV Stock Predictions
|
|
Strong Buy (4.00 out of 4) 80th percentile
(ranked higher than approx. 80% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |